Huj_Cbam_Amc_2202-2023 (No. 173/2023)_Sanofi Aventis S.A._ Framework Agreement With A Single Company Which Establishes The Conditions For The Supply Of Successive Tract And Unit Price Of Combined Tetanus-Diphtheraiia Vaccine Content Reduced Antigenic, Intended For The Andalusian Vaccination Program (Cca+6.+Idcf+7)
Hankelepingu sõlmimisteade
Teeme oma parima, et tagada veebisaidil kõige täpsemat ja värskemat teavet, aga me ei saa garanteerida vigade puudumist kogu teabes.
Kui teil on selle teate uuendamise/parandamise osas ettepanekuid, siis palun andke meile teada.
